Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hudec

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|December 7, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trialElvin Kedhi, Renicus S Hermanides, Jan-Henk E Dambrink, et al.
International Journal of Cardiology|March 1, 2020
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaborationJaya Chandrasekhar, Deborah N Kalkman, Melissa B Aquino, et al.
The American Journal of Cardiology|May 19, 2020
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)Jaya Chandrasekhar, Samantha Sartori, Melissa B Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.
American Heart Journal|February 3, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationaleElvin Kedhi, Andi Rroku, Rik S Hermanides, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 22, 2020
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaborationJaya Chandrasekhar, Laura S Kerkmeijer, Deborah N Kalkman, et al.
Cardiovascular Drugs and Therapy|January 30, 2021
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO CollaborationJaya Chandrasekhar, Vera C de Winter, Deborah N Kalkman, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trialZuzana Motovska, Ota Hlinomaz, Jan Mrozek, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|December 7, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trialElvin Kedhi, Renicus S Hermanides, Jan-Henk E Dambrink, et al.
International Journal of Cardiology|March 1, 2020
1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaborationJaya Chandrasekhar, Deborah N Kalkman, Melissa B Aquino, et al.
The American Journal of Cardiology|May 19, 2020
Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)Jaya Chandrasekhar, Samantha Sartori, Melissa B Aquino, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 9, 2020
1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO CollaborationJaya Chandrasekhar, Doreen Zeebregts, Deborah N Kalkman, et al.
American Heart Journal|February 3, 2024
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationaleElvin Kedhi, Andi Rroku, Rik S Hermanides, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 22, 2020
Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaborationJaya Chandrasekhar, Laura S Kerkmeijer, Deborah N Kalkman, et al.
Cardiovascular Drugs and Therapy|January 30, 2021
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO CollaborationJaya Chandrasekhar, Vera C de Winter, Deborah N Kalkman, et al.
JACC. Cardiovascular Interventions|June 9, 2022
Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONEStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
The New England Journal of Medicine|February 13, 2020
Polymer-based or Polymer-free Stents in Patients at High Bleeding RiskStephan Windecker, Azeem Latib, Elvin Kedhi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trialZuzana Motovska, Ota Hlinomaz, Jan Mrozek, et al.
Pageof 4